1RVTY Stock Overview

Provides health sciences solutions, technologies, and services worldwide. More details

1RVTY fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	4/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 38.9% below our estimate of its fair value

Earnings are forecast to grow 20.04% per year

Earnings grew by 61.5% over the past year

Analysts in good agreement that stock price will rise by 35.9%

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Revvity, Inc. Competitors

Fine Foods & Pharmaceuticals N.T.M

BIT:FF

€176.3m

Recordati Industria Chimica e Farmaceutica

BIT:REC

€10.9b

Eurofins Scientific

ENXTPA:ERF

€10.2b

Qiagen

NYSE:QGEN

US$9.1b

Price History & Performance

Summary of share price highs, lows and changes for Revvity
Historical stock prices
Current Share Price	US$79.86
52 Week High	US$0
52 Week Low	US$0
Beta	1.02
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.22%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1RVTY	IT Life Sciences	IT Market
7D	-2.7%	2.3%	2.1%
1Y	n/a	-4.3%	12.2%

Return vs Industry: Insufficient data to determine how 1RVTY performed against the Italian Life Sciences industry.

Return vs Market: Insufficient data to determine how 1RVTY performed against the Italian Market.

Price Volatility

Is 1RVTY's price volatile compared to industry and market?
1RVTY volatility
1RVTY Average Weekly Movement	n/a
Life Sciences Industry Average Movement	6.9%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.4%

Stable Share Price: 1RVTY's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1RVTY's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1937	11,000	Prahlad Singh	www.revvity.com

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Revvity, Inc. Fundamentals Summary

How do Revvity's earnings and revenue compare to its market cap?
1RVTY fundamental statistics
Market cap	€9.42b
Earnings (TTM)	€261.70m
Revenue (TTM)	€2.45b

36.5x

P/E Ratio

3.9x

P/S Ratio

Is 1RVTY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1RVTY income statement (TTM)
Revenue	US$2.77b
Cost of Revenue	US$1.21b
Gross Profit	US$1.56b
Other Expenses	US$1.26b
Earnings	US$296.04m

Last Reported Earnings

Mar 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	2.51
Gross Margin	56.25%
Net Profit Margin	10.69%
Debt/Equity Ratio	41.5%

How did 1RVTY perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

12%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/07 00:40
End of Day Share Price	2025/05/07 00:00
Earnings	2025/03/30
Annual Earnings	2024/12/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Revvity, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Catherine Ramsey Schulte	Baird
Luke Sergott	Barclays
Charles Butler	Barclays